Table 1.
Activity at GluN1/2X (in μM) | |||||||
---|---|---|---|---|---|---|---|
Compound | 2A | 2B | 2C | 2D | |||
NVP-AAM077 | KBa | 0.015 | 0.078 | - | - | [352] | |
TCN-201 | KBa,b | 0.045 0.070 0.027 |
NE | NE | NE | [356] [355] [158] |
|
MPX-004 | IC50c,d | 0.079c 0.198† |
NEc NE† |
-c NE† |
NEc NE† |
[357] | |
MPX-007 | IC50c,d | 0.027c 0.143† |
NEc ND† |
-c NE† |
NEc NE† |
[357] | |
GNE-3419 | EC50c | 2.03 | NR | NR | NR | [157] | |
GNE-6901 | EC50c | 0.33 | NR | NR | NR | [157] | |
GNE-0723 | EC50c | 0.021 | ND | 7.4 | 6.2 | [170] | |
GNE-8324 | EC50c | 2.43 | NR | NR | NR | [157] |
denotes not determined, NE denotes no effect at the highest concentrations evaluated, and ND indicates that the compound displayed some activity, but the affinity or potency could not be determined. NR denotes some activity, but that the numerical affinity value was not reported. Unless otherwise stated (also denoted by †), the values were determined using two-electrode voltage-clamp experiments with Xenopus oocytes.
denotes when Schild analysis was used for affinity determination.
three independent studies are published reporting the KB of TCN-201 at GluN1/2A.
denotes that potency (i.e. half maximally effective concentration) was determined using a Ca2+ imaging assay.
Experiments using MPX compounds were performed in 3 μM glycine.